Conditions: Perennial Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 489
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare the effectiveness of an Investigational use of an allergy medication (MP03-33) used to treat perennial allergic rhinitis (PAR) to placebo (a nasal spray that contains no medicine). In addition, the study will also compare the safety and effectiveness of an investigational use of another allergy medication (MP03-36) used to treat perennial allergic rhinitis to placebo.

Detailed description:
in Children Ages \>6 to \<12 with Perennial Allergic Rhinitis (PAR)

Arms:
arm 1: 822 mcg, Topical/intranasal spray, 1 spray per nostril twice daily/ 4 weeks arm 2: 548 mcg, Topical/intranasal spray, 1 spray per nostril twice daily/ 4 weeks arm 3: 0 mcg, Topical/intranasal spray, 1 spray per nostril twice daily/ 4 weeks

Interventions: intervention 1: Azelastine hydrochloride nasal spray 0.15% intervention 2: Azelastine hydrochloride nasal spray 0.10% intervention 3: Placebo
Intervention descriptions: intervention 1: 822 mcg, Topical/intranasal spray, 1 spray per nostril twice daily/ 4 weeks intervention 2: 548 mcg, Topical/intranasal spray, 1 spray per nostril twice daily/ 4 weeks intervention 3: 0 mcg, Topical/intranasal spray, 1 spray per nostril twice daily/ 4 weeks

Protocol document: